ClinicalTrials.Veeva

Menu

Symbiotics to Prevent Postoperative Infection in Colorectal Cancer

H

Hospital de Clinicas de Porto Alegre

Status

Unknown

Conditions

Surgical Site Infection
Colorectal Cancer

Treatments

Dietary Supplement: placebo group
Dietary Supplement: symbiotic group

Study type

Interventional

Funder types

Other

Identifiers

NCT02571374
symbioticcolorectalcancer

Details and patient eligibility

About

This is a double blind randomized trial in which patients with colorectal cancer undergoing surgery will be selected to receive either a symbiotic formulation or placebo. The researchers will compare incidence of surgical site infection between the study groups.

Full description

This is a double blind randomized trial in which patients with colorectal cancer undergoing surgery will be randomly selected to receive either a symbiotic formulation or placebo during the perioperative period. The researchers will compare incidence of surgical site infection, detected by clinical examination and complementary tests (CT scans, X-rays, microbiological and hematological tests) between the study groups.

Enrollment

92 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults between 18 and 85 years old;
  • Colorectal cancer patients.
  • Ability to understand and signing the informed consent

Exclusion criteria

  • Pregnancy (early diagnosis)
  • Reduced intellectual level that could prevent proper understanding of the objectives of the study
  • Patients with rectal cancer undergoing neoadjuvant treatment (chemotherapy and radiotherapy)
  • Use of products with prebiotic, probiotic and / or symbiotic function or fiber module; by more than 3x a week
  • Refusal to participate and / or to sign the Consent Form Free and Clear

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

92 participants in 2 patient groups, including a placebo group

symbiotic group
Experimental group
Description:
Symbiotic group
Treatment:
Dietary Supplement: symbiotic group
placebo group
Placebo Comparator group
Description:
placebo group
Treatment:
Dietary Supplement: placebo group

Trial contacts and locations

1

Loading...

Central trial contact

Aline Taborda, ms; Daniel Damin, dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems